AstraZeneca

NASDAQ: AZN · Real-Time Price · USD
78.87
0.40 (0.51%)
At close: Aug 15, 2025, 9:57 AM

AstraZeneca Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
8.69B 6.9B 2.5B -265M
Depreciation & Amortization
5.07B 4.93B 5.48B 6.53B
Stock-Based Compensation
n/a 579M 619M 615M
Other Working Capital
862M 969M -184M 444M
Other Non-Cash Items
-1B -2.37B -1.93B -2.32B
Deferred Income Tax
n/a n/a -619M -615M
Change in Working Capital
-893M 300M 3.76B 2.02B
Operating Cash Flow
11.86B 10.35B 9.81B 5.96B
Capital Expenditures
-4.59B -3.78B -2.57B -2.2B
Cash Acquisitions
-3.93B -1.18B -1.06B -9.43B
Purchase of Investments
-96M -136M -159M -184M
Sales Maturities Of Investments
108M 129M 42M 105M
Other Investing Acitivies
-2.14B -1.52B 789M 654M
Investing Cash Flow
-7.98B -4.06B -2.96B -11.06B
Debt Repayment
1.81B -965M -1.2B 7.89B
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-4.63B -4.48B -4.36B -3.86B
Other Financial Acitivies
-1.13B -1.15B -1.29B -418M
Financial Cash Flow
-4B -6.57B -6.82B 3.65B
Net Cash Flow
-208M -346M -55M -1.51B
Free Cash Flow
7.28B 6.57B 7.24B 3.76B